ArticleFrontiers in oncology2025

A prediction model for predicting relapsed-free survival of early-stage invasive breast cancer patients with hormone receptor positive based on Ki67, HER2 and TOP2A.

Dawei Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.